Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laure Elens

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2012
Influence of polymorphic OATP1B-type carriers on the disposition of docetaxelAnne-Joy M de Graan, Cynthia S Lancaster, Amanda Obaidat, et al.
Therapeutic Drug Monitoring|September 27, 2024
Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical ToxicologySatohiro Masuda, Florian Lemaitre, Markus J Barten, et al.
Therapeutic Drug Monitoring|March 12, 2021
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStein Bergan, Mercè Brunet, Dennis A Hesselink, et al.
Therapeutic Drug Monitoring|May 3, 2019
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus ReportMercè Brunet, Teun van Gelder, Anders Åsberg, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2012
Influence of polymorphic OATP1B-type carriers on the disposition of docetaxelAnne-Joy M de Graan, Cynthia S Lancaster, Amanda Obaidat, et al.
Therapeutic Drug Monitoring|September 27, 2024
Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical ToxicologySatohiro Masuda, Florian Lemaitre, Markus J Barten, et al.
Therapeutic Drug Monitoring|March 12, 2021
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical ToxicologyStein Bergan, Mercè Brunet, Dennis A Hesselink, et al.
Therapeutic Drug Monitoring|May 3, 2019
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus ReportMercè Brunet, Teun van Gelder, Anders Åsberg, et al.
Pageof 9